Live feed08:05:00·25dPRReleasevia QuantisnowSavara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)ByQuantisnow·Wall Street's wire, on your screen.SVRA· Savara Inc.Health Care
